Posters

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30

Sunday, September 28

4:45 PM - 6:00 PM PT

2438 - Outcomes and Toxicity of 60 Gy in 8 Fractions Stereotactic Body Radiotherapy to Peripheral Tumors Adjacent to the Chest Wall: A Single Institution Experience
Speaker: Mobayed, Tala, MD - American University of Beirut Medical Center, Beirut, Beyrouth
4:45 PM - 6:00 PM PT

2439 - A Novel Imaging Biomarker for Radiation Induced Cardiotoxicity
Speaker: Modiri, Arezoo, PhD - University of Maryland School of Medicine, Baltimore, Baltimore, MD
4:45 PM - 6:00 PM PT

2440 - Fifteen-Year Trends in Single-Fraction SBRT Utilization for Stage I Non-Small Cell Lung Cancer
Speaker: Moghanaki, Drew, MD, FASTRO, MPH - VA Greater Los Angeles, Los Angeles, CA
4:45 PM - 6:00 PM PT

2441 - Automated Radiation Response Assessment with Deep Learning and Radiomics in Pediatric Diffuse Midline Glioma
Speaker: Mojahed-Yazdi, Reza, MS - Harvard Medical School, Boston, MI
4:45 PM - 6:00 PM PT

2442 - Charlson Comorbidity Index as a Predictive Tool of Treatment Tolerance and Outcomes in Elderly Non-Small Cell Lung Cancer Patients Treated with Concurrent Proton or Photon Chemoradiation Followed by Immunotherapy
Speaker: Mollings Puentes, Cira, MD, BS - UT MD Anderson Cancer Center, Houston, TX
4:45 PM - 6:00 PM PT

2443 - Multidisciplinary Team (MDT) Perceptions toward the Treatment of Limited-Stage Small-Cell Lung Cancer (LS-SCLC): A U.S. Physician Survey
Speaker: Mora, Rebeca, MD - AstraZeneca, gaithersburg, MD
4:45 PM - 6:00 PM PT

2444 - Begin with the End in Mind: Assessing Symptom Index for Patients with Prostate Cancer to Select the Right Bladder Protocol for Radiotherapy
Speaker: Mulla, Zaheeda, RT - King Faisal Specialist Hospital and Research Centre, Jeddah, Makkah
4:45 PM - 6:00 PM PT

2445 - Comparison of the Efficacy of Immune Therapy Combined with Radiotherapy in Non-Gene-Sensitive Mutant NSCLC Brain Metastasis Patients: A Comparison of Whole-Brain Radiotherapy and Stereotactic Radiosurgery
Speaker: Munai, Erha - School of Medicine, Chongqing University, Chongqing, China, Chongqing
4:45 PM - 6:00 PM PT

2446 - Association between Geotemporal PM2.5 and Outcomes in Unresectable NSCLC Treated with Chemoradiotherapy
Speaker: Nalin, Ansel, MD, PhD - MD Anderson Cancer Center, Houston, TX
4:45 PM - 6:00 PM PT

2447 - In-Field Progression Rates Following Concurrent Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer: A Systematic Review
Speaker: Nesbit, Shannon, BS - David Geffen School of Medicine at UCLA, Los Angeles, CA
4:45 PM - 6:00 PM PT

2448 - Identification of Dosimetric and Clinical Predictors for Post-Treatment Pulmonary Hospitalizations in NSCLC
Speaker: Nieto, Josiah, MD - University of Michigan, Ann Arbor, MI
4:45 PM - 6:00 PM PT

2449 - Effects of Liberalizing Lung V5 on Intermediate and High-Dose Exposure: Insights from Lung and Esophageal Cases Treated with Photons
Speaker: Oh, Patrick, MD - Yale School of Medicine, New Haven, CT